 |
The authentic GEROVITAL H3 Dr Ana Aslan
it is made only in ROMANIA |
 |
For questions regarding authenticity of GEROVITAL H3
Dr Ana Aslan anti aging
treatment, contact
supplier Alexandru Calin (Phd in Chemistry)
VAT: RO40837257
Bucharest, Romania, Europe.
Phone: +40723141550
(whatsapp/viber/telegram)
E-mail: sales@gerovital-gh3.com
Secondary E-mail:
order.gerovital@gmail.com
|
 |
Payments
accepted:
1. Secure
Bank Transfer Wire
2.
Transferwise
3. Western
Union Online
|
Gerovital® H 3 Injections
One
vial of 5 ml solution for injection contains 100 mg procaine hydrochloride, 6
mg benzoic acid, 0.5 mg disodium phosphate dodecahydrate, 5 mg potassium
metabisulfite, and excipients: water for injections.
Gerovital® H 3 Tablets One tablet contains 100 mg
procaine hydrochloride, 6 mg benzoic acid, 0.5 mg disodium phosphate
dodecahydrate, 5 mg potassium metabisulphite and excipients: core: corn starch,
mannitol, gelatin, talc, vegetable magnesium stearate; Dragee layer:
sugar, talc, polyvidone K30, sodium carboxymethylcellulose, colloidal silicon
dioxide, polysorbate 80, titanium dioxide, shellack, Carnauba powder wax.
PHARMACOTERAPEUTICAL GROUP: Tonics,
combinations.
THERAPEUTICAL INDICATIONS
Useful in preventing aging phenomena;
Used in:
• Mild-moderate depression, especially when conventional therapy is not well tolerated or contraindicated;
• Parkinsonian syndromes - alone or in combination with antiparkinsonian drugs, especially dopaminergic agents;
• Chronic degenerative rheumatism;
• Systemic atherosclerosis accompanied by hypercholesterolemia, ischemic cardiopathy, arteritis, cerebral atherosclerosis
Useful in preventing aging phenomena;
Used in:
• Mild-moderate depression, especially when conventional therapy is not well tolerated or contraindicated;
• Parkinsonian syndromes - alone or in combination with antiparkinsonian drugs, especially dopaminergic agents;
• Chronic degenerative rheumatism;
• Systemic atherosclerosis accompanied by hypercholesterolemia, ischemic cardiopathy, arteritis, cerebral atherosclerosis
Interactions
Gerovital® H 3 should not be administered simultaneously with:
Gerovital® H 3 should not be administered simultaneously with:
•
sulphamides (antagonist mechanism of action) - except for antidiabetic agents;
• anticolinesterase: neostigmine, ezerine (physostigmine) and pyridostigmine.
• anticolinesterase: neostigmine, ezerine (physostigmine) and pyridostigmine.
SPECIAL WARNINGS
It is not recommended to use the product
during pregnancy and breast-feeding.
DOSES
AND METHOD OF ADMINISTRATIONInjections: The
recommended dose is 5 ml (1 vial) of
Gerovital®
H 3 intramuscular injection 3 times a week (1 vial of Gerovital®
H 3 solution every two days) for 4 weeks.
Tablets: The recommended dose is 2 Gerovital® H 3 tablets daily,
after meals, in the morning and in the afternoon for 24 days.
The treatment series will be followed annually, continuously or with a one-month rest period between them. The schedule and frequency of breaks will be decided by the geriatric physician, depending on the patient's condition.
Depressive syndrome:
The treatment series will be followed annually, continuously or with a one-month rest period between them. The schedule and frequency of breaks will be decided by the geriatric physician, depending on the patient's condition.
Depressive syndrome:
In the first week, the recommended
dose is 5 ml (1 ampoule) of Gerovital® H 3 injection daily,
intramuscularly, 3 times a week (for example, Monday, Wednesday and Friday);
Week two and third: the recommended dose is 7.5 ml (1 ½ ampoules) of Gerovital® H 3 injection daily, intramuscularly, 3 times per week.
In the fourth week: the recommended dose is 10 ml (2 ampoules) of Gerovital® H 3 solution for injection daily, intramuscularly 3 times a week.
Treatment should be repeated 4-6 times a year.
Parkinsonian syndromes:
Week two and third: the recommended dose is 7.5 ml (1 ½ ampoules) of Gerovital® H 3 injection daily, intramuscularly, 3 times per week.
In the fourth week: the recommended dose is 10 ml (2 ampoules) of Gerovital® H 3 solution for injection daily, intramuscularly 3 times a week.
Treatment should be repeated 4-6 times a year.
Parkinsonian syndromes:
The
recommended dose is 5 ml (1 ampoule) of Gerovital® H 3 solution for injection,
intramuscularly and 2 Gerovital® H 3 tablets daily for 15 days.
Degenerative chronic rheumatism:
Degenerative chronic rheumatism:
The recommended dose is 5 ml (1
ampoule) Gerovital solution for injection
